Teachers Advisors LLC lifted its stake in Maximus, Inc. (NYSE:MMS) by 4.1% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 124,853 shares of the health services provider’s stock after purchasing an additional 4,886 shares during the quarter. Teachers Advisors LLC owned about 0.19% of Maximus worth $7,820,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds also recently modified their holdings of the company. BlackRock Inc. boosted its position in shares of Maximus by 22,491.0% in the 1st quarter. BlackRock Inc. now owns 6,503,511 shares of the health services provider’s stock worth $404,518,000 after purchasing an additional 6,474,723 shares in the last quarter. Vanguard Group Inc. boosted its position in shares of Maximus by 8.0% in the 1st quarter. Vanguard Group Inc. now owns 5,538,187 shares of the health services provider’s stock worth $344,476,000 after purchasing an additional 411,521 shares in the last quarter. Victory Capital Management Inc. boosted its position in shares of Maximus by 8.6% in the 2nd quarter. Victory Capital Management Inc. now owns 3,100,903 shares of the health services provider’s stock worth $194,210,000 after purchasing an additional 244,823 shares in the last quarter. State Street Corp boosted its position in shares of Maximus by 2.5% in the 1st quarter. State Street Corp now owns 2,066,226 shares of the health services provider’s stock worth $128,517,000 after purchasing an additional 50,670 shares in the last quarter. Finally, Clearbridge Investments LLC boosted its position in shares of Maximus by 49.5% in the 1st quarter. Clearbridge Investments LLC now owns 2,004,270 shares of the health services provider’s stock worth $124,666,000 after purchasing an additional 663,189 shares in the last quarter. 97.23% of the stock is currently owned by hedge funds and other institutional investors.

Maximus, Inc. (NYSE MMS) opened at 65.59 on Friday. Maximus, Inc. has a 52-week low of $43.69 and a 52-week high of $65.87. The company has a market capitalization of $4.25 billion, a PE ratio of 21.02 and a beta of 1.36. The company has a 50-day moving average price of $62.23 and a 200 day moving average price of $61.79.

Maximus (NYSE:MMS) last released its quarterly earnings results on Thursday, August 3rd. The health services provider reported $0.79 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.76 by $0.03. Maximus had a net margin of 8.43% and a return on equity of 25.08%. The business had revenue of $600.40 million for the quarter, compared to analyst estimates of $614.12 million. During the same period in the previous year, the company earned $0.79 earnings per share. The business’s revenue for the quarter was down 2.7% on a year-over-year basis. Equities research analysts anticipate that Maximus, Inc. will post $3.13 earnings per share for the current year.

In other Maximus news, President Bruce Caswell sold 8,000 shares of Maximus stock in a transaction on Wednesday, July 12th. The shares were sold at an average price of $62.21, for a total value of $497,680.00. Following the transaction, the president now directly owns 35,904 shares of the company’s stock, valued at $2,233,587.84. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, General Counsel David Francis sold 3,000 shares of Maximus stock in a transaction on Thursday, October 5th. The stock was sold at an average price of $65.28, for a total transaction of $195,840.00. The disclosure for this sale can be found here. Insiders sold 160,403 shares of company stock worth $9,912,181 over the last ninety days. Corporate insiders own 3.10% of the company’s stock.

MMS has been the topic of a number of analyst reports. Canaccord Genuity cut Maximus from a “buy” rating to a “hold” rating and set a $62.00 price target on the stock. in a research report on Tuesday, July 4th. BidaskClub cut Maximus from a “strong-buy” rating to a “buy” rating in a research report on Thursday, July 6th. Zacks Investment Research cut Maximus from a “hold” rating to a “sell” rating in a research report on Tuesday, July 18th. Maxim Group set a $66.00 price target on Maximus and gave the stock a “hold” rating in a research report on Thursday, August 3rd. Finally, Robert W. Baird reissued a “hold” rating and issued a $64.00 price target on shares of Maximus in a research report on Friday, September 1st. One research analyst has rated the stock with a sell rating, eight have assigned a hold rating and one has assigned a buy rating to the stock. The company presently has a consensus rating of “Hold” and an average price target of $63.14.

TRADEMARK VIOLATION NOTICE: “Teachers Advisors LLC Has $7.82 Million Stake in Maximus, Inc. (MMS)” was posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this story on another site, it was copied illegally and republished in violation of US and international trademark & copyright law. The correct version of this story can be read at https://www.thecerbatgem.com/2017/10/06/teachers-advisors-llc-has-7-82-million-stake-in-maximus-inc-mms.html.

About Maximus

MAXIMUS, Inc provides business process services (BPS) to government health and human services agencies. The Company operates through three segments: U.S. Federal Services, Health Services and Human Services. The U.S. Federal Services segment provides BPS and program management for large government programs, independent health review and appeals services for both the United States Federal Government, and state-based programs and technology solutions for civilian federal programs.

Institutional Ownership by Quarter for Maximus (NYSE:MMS)

Receive News & Stock Ratings for Maximus Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus Inc. and related stocks with our FREE daily email newsletter.